Real-Time Wear Testing (RWT)

Real-time wear testing (RWT) is intended to match physiological loading conditions as closely as possible as to what would be obtained in a real patient. Due to the viscoelastic nature of some materials, Accelerated Wear Testing may actually under test devices, so RWT can be used to identify frequency dependent failure modes.

Test Procedure

Testing durations of 50 million cycles or greater will be performed.

Testing at physiologic conditions (beat rates < 200 BPM).

The target differential pressure shall be maintained across the closed valve for 20 % of the cycle.

A detailed description of valve appearance (photographs and videos)  along with  hydrodynamic functional evaluations shall be made at 0, 25, and 50 millions cycles. These results should be compared to results achieved during Accelerated Wear Testing (AWT). Note this may require an additional inspection point during AWT at 25 million cycles, as this is not typically performed.



Measured Parameters

  • Number of Cycles conforming to loading conditions (target pressures across the closed valve were attained for at least 5 % of each cycle)
  • Sample pressure waveforms
  • Opening and closing kinematics under highspeed video
  • Photographic documentation of the appearance of the test sample at defined inspection intervals
  • Hydrodynamic performance at defined inspection intervals


  • Critical for viscoelastic materials
  • Required for devices without established clinical history
  • Recommended for devices which may not survive the severe loading typically imparted by accelerated testing
  • Surgical Valves: SAVR, SMVR, SPVR, STVR
  • Transcatheter Valves: TAVI / TAVR, TMVI / TMVR, TPVI / TPVRTMVR, TTVR / TTVI  and any other transcatheter valve
  • Biological, Polymeric, mechanical valves, tissue engineered
  • Artificial heart valves prosthesis
  • Venous valves
  • Valvular conduits
  • Any valvular prosthesis
  • Any cardiac repair device

Service Levels

Applicable Standards

  • ISO 5840-1:2021
    Cardiovascular implants — Cardiac valve prostheses — Part 1: General requirements

  • ISO 5840-2:2021
    Cardiovascular implants — Cardiac valve prostheses — Part 2: Surgically implanted heart valve substitutes

  • ISO 5840-3:2021
    Cardiovascular implants — Cardiac valve prostheses — Part 3: Heart valve substitutes implanted by transcatheter techniques

  • ISO 5910:2018
    Cardiovascular implants and extracorporeal systems — Cardiac valve repair devices

Related Tests


ViVitro Labs Advantages

Many companies look to academia to handle their testing needs due to the reduced cost. With ViVitro Laboratory Services you gain the following advantages:

ISO 17025 Accredited
For studies used for regulatory approval this is a must. Victoria and Marseille labs accredited by A2LA.

Test Method Validation
The FDA and Notified Bodies around the world are requiring evidence of Test Method Validation. ViVitro Labs has invested significant resources to validate the most common test methods that are not ISO 17025 accredited. We continue to work closely with device manufacturers and share the burden with our clients to validate other specific test methods that are less in demand.

We understand how critical your timelines are. Our expertise and experience ensure your schedule is met and our commitments are delivered on time.

Free Initial Consultations
All of our studies are scoped via no-cost, no obligation, collaborative consultation.

Guaranteed Confidentiality
We happily provide Non-Disclosure Agreements for all services, including initial consultation.

Join over 5000 cardiovascular device professionals who receive our testing and engineering insights and tips every month.